Home/Specialty/Hematology/Test, Qualitative And Quantitative Factor Deficiency/TriniLIZE™ PAI-1 Activity

TCOAG IRELAND LIMITED T6004 TriniLIZE™ PAI-1 Activity

Company Name

TCOAG IRELAND LIMITED

Catalog Number

T6004

Have questions, or need more information? Contact Us

Pricing
Summary

Price Not Available

Out of Stock

Interested in this product?
Contact us or login to add to your watchlist.

Related Items

Precision Biologic Inc CCCF09 CRYOcheck Chromogenic Factor IX

CRYOcheck Chromogenic Factor IX is for clinical laboratory use in the quantitative determination of factor IX activity in 3.2% citrated human plasma. It is intended to be used in identifying factor IX deficiency and as an aid in the management of hemophilia B in individuals aged 2 years and older. For in vitro diagnostic use

TCOAG IRELAND LIMITED T1602 TriniCLOT™ Protein S

TCOAG IRELAND LIMITED T2608 TriniCHROM™ Factor VIII:C

TCOAG IRELAND LIMITED T6003 TriniLIZE™ PAI-1 Antigen

TCOAG IRELAND LIMITED 50710 Lyophilized Platelets

Precision Biologic Inc CCIK08 CRYOcheck™ FVIII Inhibitor Kit

The CRYOcheck FVIII Inhibitor Kit is for clinical laboratory use in conjunction with a factor VIII activity assay to enable performance of a modified Nijmegen-Bethesda assay using 3.2% citrated human plasma. It enables the determination of a functional FVIII inhibitor titer to aid in the clinical management of congenital hemophilia A in individuals aged 2 years and older.

Precision Biologic Inc CCCF09 CRYOcheck Chromogenic Factor IX

CRYOcheck Chromogenic Factor IX is for clinical laboratory use in the quantitative determination of factor IX activity in 3.2% citrated human plasma. It is intended to be used in identifying factor IX deficiency and as an aid in the management of hemophilia B in individuals aged 2 years and older. For in vitro diagnostic use

Precision Biologic Inc CCIK08 CRYOcheck™ FVIII Inhibitor Kit

The CRYOcheck FVIII Inhibitor Kit is for clinical laboratory use in conjunction with a factor VIII activity assay to enable performance of a modified Nijmegen-Bethesda assay using 3.2% citrated human plasma. It enables the determination of a functional FVIII inhibitor titer to aid in the clinical management of congenital hemophilia A in individuals aged 2 years and older.

Precision Biologic Inc CCCF09 CRYOcheck Chromogenic Factor IX

CRYOcheck Chromogenic Factor IX is for clinical laboratory use in the quantitative determination of factor IX activity in 3.2% citrated human plasma. It is intended to be used in identifying factor IX deficiency and as an aid in the management of hemophilia B in individuals aged 2 years and older. For in vitro diagnostic use

Additional Details

Device Identifier

05391521420909

Is RX

Yes

Is Over the Counter

No

Requires Sterilization

No

Is Sterile

No

Is Single Use

No

Categories

Barcode Mapping

Unit of Measurement	Eaches	GTIN
Each	1	05391521420909